At a glance
ClinicalIndex Comparison RecordN/ACompleted· 30,430 enrolled
Drug / intervention
Rocuronium +6 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Use of Neuromuscular Blocking Agents and Neuromuscular Monitoring in 7 Danish Teaching Hospitals - a Cross-sectional Study
In Brief
An observational study evaluating Rocuronium, Succinylcholine, and 5 other interventions for Neuromuscular Blockade. Completed, enrolled 30,430 participants across 1 site.
Detailed Summary
Aim: To explore * the frequency of use of objective neuromuscular monitoring for assessment of depth of neuromuscular blockade in general anaesthesia * the incidence of residual neuromuscular blockade, and * the timing of reversal of the neuromuscular blockade at the end of anaesthesia. We will collect data from 7 Danish anaesthesia departments, using data from the Anaesthesia Information Management System (AIMS).
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsNeuromuscular Blockade
CountriesDenmark
CollaboratorsMerck Sharp & Dohme LLC
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedSep 2016
Enrollment StartOct 2016
Primary CompletionJun 2017
TodayJul 2026
First PostedSep 26, 2016
Enrollment StartOct 1, 2016
Primary CompletionJun 1, 2017
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 9.8 years ago
Interventions
Rocuroniumdrug
Succinylcholinedrug
Cisatracuriumdrug
Mivacuriumdrug
Objective neuromuscular monitoring (acceleromyography)device
Sugammadexdrug
Neostigminedrug